Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,467 public trials 2,848 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Enrolling by invitation

Analysis of the Therapeutic and Clinical Profile of Cannabinoid Treatments: A Real-World Study

NCT07362407

Conditions: Anxiety Disorders, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +34 more
Locations: Universidade Federal de Santa Catarina (UFSC), Centro de Ciências Biológicas (CCB), Campus Universitário, Trindade, Florianópolis - SC. Florianópolis, Santa Catarina, Brazil

View Trial Details

Enrolling by invitation

Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors

NCT06211413

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Cardiotoxicity, +25 more
Locations: Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Enrolling by invitation

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

NCT07474051

Conditions: AML (Acute Myelogenous Leukemia), B-cell Lymphoma, Chronic Disease, +33 more
Locations: Charité Universitätsmedizin Berlin Berlin, Germany

Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus Dresden, Germany

Universitätsklinikum Marburg Marburg, Germany

Klinikum der Universität (LMU) Muenchen Munich, Germany

View Trial Details

Enrolling by invitation

Long-Term Follow-up Study

NCT05332054

Conditions: B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
Locations: University of Alabama Birmingham, Alabama, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Honor Health Research Institute Scottsdale, Arizona, United States

University of California Irvine Irvine, California, United States

View all 31 locations

View Trial Details

Enrolling by invitation

Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network

NCT07445347

Conditions: Bevacizumab, Cardiovascular Abnormalities, Cardiovascular Diseases, +16 more
Locations: Centre hospitalier universitaire de Poitiers Poitiers, France

View Trial Details

Enrolling by invitation

pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)

NCT06253507

Conditions: Autosomal Recessive, Chronic Disease, Chronic Granulomatous Disease, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Enrolling by invitation

AI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities

NCT07410403

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Enrolling by invitation

A Long-term Follow-up Study in Participants Who Received CS-101

NCT06685536

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Enrolling by invitation

A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection

NCT06717932

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, China

View Trial Details

Enrolling by invitation

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

NCT07383298

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions